The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Trastuzumab deruxtecan Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
BeOne Medicines Reaches U.S. Government Agreement to Expand Access to Cancer Medicines
Servier Pharmaceuticals Is Pleased to Welcome Jerome Klein
Could Olanzapine Change the Way We Prevent Radiation-Induced Nausea?
From Poison to Pill: The History and Future of Arsenic Therapy in Leukemia
Aakash Desai: Top Picks for WCLC 2026
Talha Badar: Azacitidine or Decitabine for Newly Diagnosed TP53-Mutant AML?
